Skip Navigation

Johns Hopkins Pituitary Center Man stands on cliff and breathes deeply, face lifted to the sky

The Johns Hopkins Pituitary Center specializes in diagnosis and treatment of people who have pituitary tumors and other pituitary disorders. Our multi-specialty team offers a full range of treatments, including observation, drug therapies, radiation and surgery. We create comprehensive treatment plans tailored for each patient, considering age, health status and other factors. We are also testing new medications and work on discovering genetic risk factors for pituitary tumors.


Pituitary Specialists

Our team includes experts in neurosurgery, endocrinology, neuro-ophthalmology, otolaryngology, pathology and radiation oncology, as well as advanced practitioners and nurses skilled in providing specialized care. This diverse team of experts meets monthly to share their insights and confer on treatment approaches.


Conditions We Treat

Johns Hopkins Pituitary Patient Education Day

The annual Pituitary Patient Education Day is a free event that features presentations from Johns Hopkins pituitary experts.

Event Details

When: Saturday, Oct. 7, 2023 | 9 a.m. - 1 p.m.

Where: The Johns Hopkins Hospital Chevy Chase Conference Center, Zayed Tower
1800 Orleans St.
Baltimore MD 21287

To RSVP, please email [email protected]. Space is limited. One member per family is encouraged to attend.



Clinical Trials

The Pituitary Center is actively recruiting participants for the following studies. If interested, contact the study coordinator at 410-502-0033 or Roberto Salvatori, M.D., principal Investigator, at 410-955-3921 or [email protected].

  • Principle Investigator: Roberto Salvatori, MD
    Objective: This is a study to determine if the research drug, relacorilant, is safe and effective for people with Cushing's syndrome.
    Eligibility Criteria: People with Cushing's Syndrome (Cushing's Disease).
    More information on NCT03697109

  • Principle Investigator: Roberto Salvatori, MD
    Objective: This is a study to determine if the research drug, paltusotine, is safe and effective in controlling growth hormone (GH) levels in people with acromegaly.
    Eligibility Criteria: People 18 years or older with acromegaly who are currently receiving and have responded to injections of octreotide or lanreotide as treatment.
    More information on NCT04837040

  • Principle Investigator: Roberto Salvatori, MD
    Objective: This is a study to survey the treatment of acromegaly through electronic data collection.
    Eligibility Criteria: Patients with acromegaly.


Support the Pituitary Center

At Johns Hopkins, we have a long-standing tradition of delivering the best neurological and neurosurgical care as well as pushing the frontiers forward and developing new therapies. Your support helps us make new discoveries and improve care for our patients.


Appointments and Referrals

To arrange evaluations and request appointments, patients or their physicians can call 410-955-9270 to speak with an agent who can begin the scheduling process.

  • To better assess how to help you, a scheduling agent may ask you to send the following information. You or your physician can fax it to 410-630-7504:

    • Relevant laboratory test results
    • MRI reports (please do not send original films)
    • Referring physician and clinic notes
    • Copy of insurance card, front and back

    It also helps to contact your insurance company to verify your coverage. Once we receive and review all completed forms and records, we will contact you to coordinate appointment(s) and arrange for forwarding any original films if necessary.

  • Please bring the following to your first appointment:

    • All recent MRI scans relevant to your condition (actual images are preferred over CDs)
    • Recent laboratory/blood reports
    • Completed new patient questionnaire

    Please arrive 15 minutes before your appointment. Feel free bring a book or snack so that you are comfortable before and between appointments with various physicians.

  • To follow up on your referral or provide additional information, physicians can call 410-955-4526.

    The Pituitary Tumor Center staff will review the patient’s records and schedule appointments within approximately five business days.

back to top button